These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 8595627

  • 1. KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.
    Ferdinandy P, Szilvássy Z, Droy-Lefaix MT, Tarrade T, Koltai M.
    Cardiovasc Res; 1995 Nov; 30(5):781-7. PubMed ID: 8595627
    [Abstract] [Full Text] [Related]

  • 2. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
    Tosaki A, Szerdahelyi P, Engelman RM, Das DK.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798
    [Abstract] [Full Text] [Related]

  • 3. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
    Docherty JC, Gunter HE, Kuzio B, Shoemaker L, Yang L, Deslauriers R.
    J Mol Cell Cardiol; 1997 Jun; 29(6):1665-73. PubMed ID: 9220352
    [Abstract] [Full Text] [Related]

  • 4. Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/reperfused hearts.
    Tosaki A, Engelman DT, Engelman RM, Das DK.
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1115-23. PubMed ID: 8531071
    [Abstract] [Full Text] [Related]

  • 5. Effect of potassium channel blockade on the anti-ischemic actions of mechanistically diverse agents.
    Sargent CA, Smith MA, Dzwonczyk S, Sleph PG, Grover GJ.
    J Pharmacol Exp Ther; 1991 Oct; 259(1):97-103. PubMed ID: 1920138
    [Abstract] [Full Text] [Related]

  • 6. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
    Grover GJ, McCullough JR, Henry DE, Conder ML, Sleph PG.
    J Pharmacol Exp Ther; 1989 Oct; 251(1):98-104. PubMed ID: 2507775
    [Abstract] [Full Text] [Related]

  • 7. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.
    Tosaki A, Hellegouarch A.
    J Am Coll Cardiol; 1994 Feb; 23(2):487-96. PubMed ID: 8294705
    [Abstract] [Full Text] [Related]

  • 8. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
    Lee SH, Yang MK, Lim JH, Seo HW, Yi KY, Yoo SE, Lee BH, Won HS, Lee CS, Choi WS, Shin HS.
    Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
    [Abstract] [Full Text] [Related]

  • 9. Cardioprotective effects of a novel calcium antagonist related to the structure of cromakalim.
    Grover GJ, Sleph PG, Dzwonczyk S, McCullough JR.
    J Pharmacol Exp Ther; 1993 Oct; 267(1):102-7. PubMed ID: 8229736
    [Abstract] [Full Text] [Related]

  • 10. Inhibitors of nitric oxide synthesis and ischemia/reperfusion attenuate coronary vasodilator response to pinacidil in isolated rat heart.
    Maczewski M, Beresewicz A.
    J Physiol Pharmacol; 1997 Dec; 48(4):737-49. PubMed ID: 9444621
    [Abstract] [Full Text] [Related]

  • 11. Cardioprotective effect of enantiomers of cicletanine (BN50417, BN50418) in ischaemic/reperfused isolated working rat hearts: interaction with glibenclamide.
    Ferdinandy P, Szilvássy Z, Csont T, Koltai M, Droy-lefaix MT.
    Pharmacol Res; 1999 Mar; 39(3):225-31. PubMed ID: 10094849
    [Abstract] [Full Text] [Related]

  • 12. The cardioprotective and electrophysiological effects of cromakalim are attenuated by meclofenamate through a cyclooxygenase-independent mechanism.
    Grover GJ, D'Alonzo AJ, Sleph PG, Dzwonczyk S, Hess TA, Darbenzio RB.
    J Pharmacol Exp Ther; 1994 May; 269(2):536-40. PubMed ID: 8182522
    [Abstract] [Full Text] [Related]

  • 13. Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening.
    Grover GJ, D'Alonzo AJ, Hess T, Sleph PG, Darbenzio RB.
    Cardiovasc Res; 1995 Nov; 30(5):731-8. PubMed ID: 8595620
    [Abstract] [Full Text] [Related]

  • 14. [Cardioprotective effect of cromakalim, a K+ channel opener, on isolated globally ischemic and reperfused rat hearts].
    Taki H, Masuda Y, Yoshizumi M, Kitagawa T, Katoh I.
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Mar; 41(3):438-44. PubMed ID: 8478573
    [Abstract] [Full Text] [Related]

  • 15. K(ATP)-channel activation: effects on myocardial recovery from ischaemia and role in the cardioprotective response to adenosine A1-receptor stimulation.
    Ford WR, Lopaschuk GD, Schulz R, Clanachan AS.
    Br J Pharmacol; 1998 Jun; 124(4):639-46. PubMed ID: 9690854
    [Abstract] [Full Text] [Related]

  • 16. Effect of potassium on the action of the KATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemia.
    D'Alonzo AJ, Darbenzio RB, Hess TA, Sewter JC, Sleph PG, Grover GJ.
    Cardiovasc Res; 1994 Jun; 28(6):881-7. PubMed ID: 7923295
    [Abstract] [Full Text] [Related]

  • 17. Extracellular Mg++ manipulation prevents the proarrhythmic activity of cromakalim in ischemic/reperfused diabetic hearts.
    Tosaki A, Das DK.
    J Pharmacol Exp Ther; 1997 Jul; 282(1):309-17. PubMed ID: 9223569
    [Abstract] [Full Text] [Related]

  • 18. Antiarrhythmic effect of ischemic preconditioning during low-flow ischemia. The role of bradykinin and sarcolemmal versus mitochondrial ATP-sensitive K(+) channels.
    Driamov S, Bellahcene M, Ziegler A, Barbosa V, Traub D, Butz S, Buser PT, Zaugg CE.
    Basic Res Cardiol; 2004 Jul; 99(4):299-308. PubMed ID: 15221348
    [Abstract] [Full Text] [Related]

  • 19. The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts.
    Grover GJ, Dzwonczyk S, Sleph PG, Sargent CA.
    J Pharmacol Exp Ther; 1993 May; 265(2):559-64. PubMed ID: 8496806
    [Abstract] [Full Text] [Related]

  • 20. KATP channel modulators and myocardial damages induced by ischemia-reperfusion: membrane lipids injury and arrhythmias.
    Picard S, Rouet R, Duval D, Chesnay F, Gérard JL.
    J Mol Cell Cardiol; 1998 Dec; 30(12):2613-21. PubMed ID: 9990533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.